[Late cutaneous porphyria with sclerodermic syndrome revealed by taking estrogens, barbiturates and estro-progestational hormones].
D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000009:adverse effects*; D008656:Mestranol / Q000009:adverse effects*; D010634:Phenobarbital / Q000009:adverse effects*; D011164:Porphyrias / Q000139:chemically induced*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced*; D012595:Scleroderma, Systemic / Q000139:chemically induced*
D008656:Mestranol; D008234:Lynestrenol; D010634:Phenobarbital
Porphyrie cutanée tardive avec syndrome sclérodermique révélée par la prise d'oestrogènes, barbituriques, oestro-progestatifs.